Skip to content
Screener

Integra LifeSciences IART Balance Sheet Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$214.42M-1.6%$236.81M-1.0%$235.05M-4.6%$232.19M+7.9%$217.91M+1.2%
$59.67M+67.2%$28.69M-16.1%$28.69M+5.5%$35.69M-42.8%$35.69M-56.3%
$267.19M-6.1%$264.41M+4.7%$278.85M+2.4%$262.16M+5.6%$284.51M+4.9%
$492.01M+5.8%$495.04M+11.1%$492.74M+14.8%$489.11M+11.9%$465.13M+10.3%
$1.19B+4.3%$1.17B+5.8%$1.16B+7.2%$1.14B+4.0%$1.14B+2.7%
$446.2M+2.6%$446.88M+5.7%$444.34M+9.5%$437.37M+11.9%$434.82M+16.4%
$611.15M-0.9%$613.25M-44.5%$615.16M-43.9%$615.2M-44.9%$616.43M-44.2%
$1.08B-9.5%$1.11B-6.9%$1.13B-6.0%$1.16B-4.1%$1.19B-2.6%
$3.56B-2.8%$3.58B-11.7%$3.6B-10.8%$3.65B-10.3%$3.67B-10.0%
$82.64M-11.0%$87.95M-3.7%$95.73M+16.0%$92.31M+18.8%$92.84M-13.6%
$11.7M+5.4%$11.62M+10.3%$11.46M+9.3%$11.33M+13.4%$11.1M+12.1%
$53.28M+37.5%$53.28M+37.5%$38.75M+14.3%$38.75M+14.3%
$330.88M-64.4%$346.85M-62.2%$455.98M-50.6%$364.05M-60.1%$929.81M+183%
$1.74B+55.3%$1.75B+55.1%$1.73B+59.0%$1.71B+50.9%$1.12B-2.9%
$2.52B-4.2%$2.54B+0.3%$2.56B+2.7%$2.61B+2.5%$2.63B+3.5%
240M0.0%240M0.0%923K+0.8%240M0.0%240M0.0%
$423.31M-1.7%$418.82M-54.2%$423.44M-54.9%$425.15M-53.8%$430.55M-53.8%
$1.04B+0.5%$1.04B-31.6%$1.04B-32.5%$1.04B-31.8%$1.04B-32.3%
$3.56B-2.8%$3.58B-11.7%$3.6B-10.8%$3.65B-10.3%$3.67B-10.0%

FAQ

What are Integra LifeSciences's total assets?
Integra LifeSciences (IART) holds $3.6B in total assets, down 2.9% year over year.
How much debt does Integra LifeSciences have?
Integra LifeSciences carries $2.0B in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 1.88.
How much cash does Integra LifeSciences have?
Integra LifeSciences holds $214.4M in cash and equivalents.
Can Integra LifeSciences cover its short-term obligations?
Its current ratio is 3.60 — current assets exceed current liabilities.
Where does Integra LifeSciences's balance sheet data come from?
Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.